| Literature DB >> 35808126 |
Siti Fatimah Nur Abdul Aziz1, Abu Bakar Salleh2, Siti Efliza Ashari3, Yahaya M Normi2,4,5, Nor Azah Yusof1,4, Shahrul Ainliah Alang Ahmad1,4.
Abstract
This work presents the use of encapsulated mini protein 20 mimicking uricase (mp20)-zeolitic imidazolate framework-8 (ZIF-8) as a bioreceptor for the development of a nanozyme-based electrochemical biosensor for uric acid detection. The electrochemical performance of the biofunctionalized mp20@ZIF-8 on the reduced graphene oxide/screen-printed carbon electrode (rGO/SPCE) was investigated by optimizing operating parameters such as pH, deposition potential, and deposition time using a central composite design-response surface methodology (CCD-RSM). The quadratic regression model was developed to correlate the combination of each variable to the oxidation current density as a response. A significant effect on current response was observed under optimized conditions of pH of 7.4 at -0.35 V deposition potential and 56.56 s deposition time, with p < 0.05 for each interacted factor. The obtained coefficient of determination (R2) value of 0.9992 indicated good agreement with the experimental finding. The developed nanozyme biosensor (mp20@ZIF-8/rGO/SPCE) exhibited high selectivity in the presence of the same fold concentration of interfering species with a detection limit of 0.27 μM, over a concentration range of 1 to 34 μM. The practicality of the tailored biosensor in monitoring uric acid in human serum and urine samples was validated with high-performance liquid chromatography (HPLC) and a commercial uric acid meter. Hence, nanozyme-based is a promising platform that offers a rapid, sensitive, selective, and low-cost biosensor for the non-enzymatic detection of uric acid in biological samples.Entities:
Keywords: RSM; ZIFs; nanozymes; uric acid; uricase
Year: 2022 PMID: 35808126 PMCID: PMC9267977 DOI: 10.3390/nano12132290
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.719
Figure 1Flow chart of RSM optimization studies for uric acid detection based on mp20@ZIF-8/rGO/SPCE electrode.
Figure 2(A) PXRD patterns of ZIF-8 and mp20 encapsulated into ZIF-8 (mp20@ZIF-8) as compared to simulated pattern; (B) Raman spectra of GO and rGO on SPCE surface.
Figure 3FESEM images display respective (A) rGO/SPCE, (B) ZIF-8/rGO/SPCE, and (C) mp20@ZIF-8/rGO/SPCE morphologies at 100kx magnification and histogram on particles size distribution of (D) ZIF-8/rGO/SPCE and (E) mp20@ZIF-8/rGO/SPCE.
Figure 4Nyquist plots of modified SPCEs in 5 mM Fe(CN)63−/4− in presence of 0.1 M KCl solution. The frequency range is 1 Hz to 100 kHz, and the amplitude is 0.2 V. The inset shows a magnification Nyquist plot of rGO/SPCE (below) and Randles equivalent circuit applied to fit the data (above).
Statistical parameter of the model equation as obtained from ANOVA models.
| Variables | Value |
|---|---|
| Standard Deviation (SD) | 0.038 |
| Mean | 4.57 |
| Coefficient of Variation (CV) | 0.84 |
| Predicted Residual Error Sum of Squares (PRESS) | 0.14 |
| R2 | 0.9992 |
| Adjusted R2 | 0.9983 |
| Predicted R2 | 0.9904 |
| Adequate Precision | 85.389 |
Predicted and observed response values performed at optimum conditions of uric acid detection by mp20@ZIF-8/rGO/SPCE.
| Number | pH | Deposition Potential, V | Deposition Time, s | Current, μA | RSE (%) | |
|---|---|---|---|---|---|---|
| Predicted | Experiment | |||||
| 1 | 7.4 | −0.35 | 56.56 | 5.20 | 5.19 | 0.19 |
| 2 | 7.4 | −0.3 | 50.56 | 5.09 | 5.00 | 1.76 |
| 3 | 7.4 | −0.4 | 46.56 | 5.10 | 5.08 | 0.39 |
| 4 | 7.4 | −0.2 | 66.56 | 4.88 | 4.90 | 0.41 |
| 5 | 7.4 | −0.45 | 40.56 | 4.85 | 4.86 | 0.21 |
Figure 5(A) DPV of the mp20@ZIF-8/rGO/SPCE after spiking of different uric acid concentrations in 0.1 M PBS at pH 7.4, and (B) calibration curve of current density as a function of the UA concentration.
A comparison of different electrochemical biosensors for the detection of uric acid.
| Fabricated Sensor | Linear Range (μM) | Detection Limit (μM) | Ref. |
|---|---|---|---|
| UOX-HRP, entrapment, carbon paste covered with poly(o-aminophenol) | Up to 100 | 3.0 | [ |
| UOX, glutaraldehyte cross-linking, polypyrrole membrane | 1.0–50 | 0.5 | [ |
| uricase onto GO | 20–490 | 3.45 | [ |
| immobilizing uricase in crosslinked chitosan network through glutaraldehyde, onto PBNPs/c-MWCNT/PANI/Au modified electrode | 5–800 | 5.0 | [ |
| UOx/EDC:NHS/CZTS/ITO- | 50–700 | 0.066 | [ |
| Uricase-overproducing strains of | Up to 180 | 8.0 | [ |
| mp20 encapsulated ZIF-8 on reduced graphene oxide (mp20@ZIF-8/rGO/SPCE) electrode | 1–34 | 0.27 | present work |
Figure 6The proposed electrochemical oxidation of uric acid.
Representative data of magnitude current changes during uric acid detection with the presence of several interferents at the same fold concentration (22 μM) in 0.1 M PBS solution at pH 7.4 and the mp20@ZIF-8/rGO/SPCE biosensor stability over time.
| Signal Changed (%) | RSD (%) | |
|---|---|---|
|
| ||
| Ascorbic Acid | 1.73 | 0.83 |
| Urea | 3.56 | 0.75 |
| Glucose | 3.08 | 2.68 |
| L-Cysteine | 2.70 | 3.46 |
| Creatinine | 0.71 | 1.64 |
|
| ||
| 14 | 4 | 1.0 |
| 30 | 7 | 2.5 |
| 60 | 7 | 0.1 |
| 180 | 8 | 1.08 |
Figure 7Data validation of uric acid in physiological fluids.
Figure 8Data validation of uric acid by biosensor mp20@ZIF-8/rGO/SPCE and UA meter in physiological fluids; (A) human serum and (B) urine.